Company: VERA
Filing Date: 2025-02-26
Form Type: 8-K
Source: 0000950170-25-027337
Chunk: 1

Company: Vera Therapeutics, Inc.
Filing Date: 2025-02-26
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                   
         99.1      Press Release of Vera Therapeutics, Inc., dated February 26, 2025.            
 ─────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                             Vera Therapeutics, Inc.              
  Date:      February 26, 2025      By:      /s/ Sean Grant                       
                                             Sean Grant, Chief Financial Officer